

PMX 53 acetate(219639-75-5 free base)
CAS No. 852629-88-0
PMX 53 acetate(219639-75-5 free base)( —— )
Catalog No. M37923 CAS No. 852629-88-0
PMX-53 is a potent and orally active CD88 (C5aR) antagonist (IC50: 20 nM) and inhibits C5a-induced neutrophil myeloperoxidase release and chemotaxis with IC50 values of 22 nM and 75 nM, respectively.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 172 | Get Quote |
![]() ![]() |
5MG | 245 | Get Quote |
![]() ![]() |
10MG | 363 | Get Quote |
![]() ![]() |
25MG | 545 | Get Quote |
![]() ![]() |
50MG | 751 | Get Quote |
![]() ![]() |
100MG | 981 | Get Quote |
![]() ![]() |
200MG | 1332 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePMX 53 acetate(219639-75-5 free base)
-
NoteResearch use only, not for human use.
-
Brief DescriptionPMX-53 is a potent and orally active CD88 (C5aR) antagonist (IC50: 20 nM) and inhibits C5a-induced neutrophil myeloperoxidase release and chemotaxis with IC50 values of 22 nM and 75 nM, respectively.
-
DescriptionPMX-53 is a potent and orally active CD88 (C5aR) antagonist (IC50: 20 nM) and inhibits C5a-induced neutrophil myeloperoxidase release and chemotaxis with IC50 values of 22 nM and 75 nM, respectively. PMX-53 is also an agonist of Mas-related gene 2 (MrgX2).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetComplement System
-
RecptorComplement System
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number852629-88-0
-
Formula Weight956.16
-
Molecular FormulaC49H69N11O9
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN=C(N)NCCC[C@@H]1NC([C@H](CC2=CNC3=C2C=CC=C3)NC([C@@H](CC4CCCCC4)NC([C@H]5N(C([C@H](CCCNC1=O)NC([C@H](CC6=CC=CC=C6)NC(C)=O)=O)=O)CCC5)=O)=O)=O.CC(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
PMX 53 acetate(21963...
PMX-53 is a potent and orally active CD88 (C5aR) antagonist (IC50: 20 nM) and inhibits C5a-induced neutrophil myeloperoxidase release and chemotaxis with IC50 values of 22 nM and 75 nM, respectively.
-
C3a 70-77
C3a 70-77 is an octapeptide corresponding to the COOH terminus of C3a.
-
Sutimlimab
Sutimlimab is a novel monoclonal antibody targeting complement protein C1. Sutimlimab is commonly used as a C1 inhibitor to treat cold agglutina-associated hemolysis.